Sponsored Links
| New TAU Formulation May Slow Down Parkinson's, Alzheimer's And Huntington's Diseases |
 |
 |
 |
| Medical News - Huntingtons Disease | |||
|
Working like an architect, Prof. Hagit Eldar-Finkelman of Tel Aviv University's Sackler School of Medicine is "building" a new drug, L803-MTS, to treat a number of central nervous system (CNS) diseases like Alzheimer's. In pre-clinical studies, it also shows promise against Parkinson's, Huntington's and diabetes. L803-MTS is based on the physical structure of the GSK3 protein, which plays a causative role in insulin resistance and Type II diabetes. Read more: Huntingtons Disease News From Medical News Today
|